Ritesh Agarwal
Impact in
- Infectious Diseases top 0.1%
- Antifungal resistance and susceptibility
- Pulmonary and Respiratory Medicine top 0.1%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Respiratory and Cough-Related Research
- Pleural and Pulmonary Diseases
- Lung Cancer Diagnosis and Treatment
- Respiratory Support and Mechanisms
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 57
- Pleural and Pulmonary Diseases 44
- Respiratory Support and Mechanisms 43
- Tracheal and airway disorders 37
- Respiratory and Cough-Related Research 35
- Lung Cancer Diagnosis and Treatment 32
-
- Antifungal resistance and susceptibility 149
- Co-authors
- Ashutosh N. Aggarwal (235 shared papers)Sahajal Dhooria (211 shared papers)Dheeraj Gupta (63 shared papers)Arunaloke Chakrabarti (99 shared papers)Inderpaul Singh Sehgal (184 shared papers)Valliappan Muthu (154 shared papers)Surinder K. Jindal (27 shared papers)Mandeep Garg (77 shared papers)
- Journals
- Mycoses (43 papers)CHEST Journal (30 papers)Respiratory Care (28 papers)Mycopathologia (16 papers)PLoS ONE (11 papers)
- Partner nations
- IndiaUnited StatesUnited Kingdom
In The Last Decade
Ritesh Agarwal
522 papers receiving 14.6k citations
Ritesh Agarwal's Hit Papers
Peers
Comparison fields: 5 of 177
- Infectious Diseases 5.3k
- Pulmonary and Respiratory Medicine 6.5k
- Critical Care and Intensive Care Medicine 616
- Physiology 3.1k
- Hepatology 768
Countries citing papers authored by Ritesh Agarwal
This map shows the geographic impact of Ritesh Agarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritesh Agarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritesh Agarwal more than expected).
Fields of papers citing papers by Ritesh Agarwal
This network shows the impact of papers produced by Ritesh Agarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritesh Agarwal. The network helps show where Ritesh Agarwal may publish in the future.
Co-authors
The 25 scholars most cited alongside Ritesh Agarwal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 548 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria Hit paper breakdown → | 2013 | 620 |
| 2 | 2007 | 452 | |
| 3 | Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature Hit paper breakdown → | 2021 | 381 |
| 4 | 1997 | 311 | |
| 5 | 2009 | 295 | |
| 6 | Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India Hit paper breakdown → | 2021 | 290 |
| 7 | A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India Hit paper breakdown → | 2019 | 243 |
| 8 | 2012 | 196 | |
| 9 | 2007 | 181 | |
| 10 | 2012 | 180 | |
| 11 | 2006 | 175 | |
| 12 | 2007 | 172 | |
| 13 | 2010 | 165 | |
| 14 | Inhibition of skin tumor promoter-caused induction of epidermal ornithine decarboxylase in SENCAR mice by polyphenolic fraction isolated from green tea and its individual epicatechin derivatives. | 1992 | 156 |
| 15 | Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. | 2009 | 149 |
| 16 | 2010 | 148 | |
| 17 | 2021 | 144 | |
| 18 | 2021 | 144 | |
| 19 | 2011 | 140 | |
| 20 | 2013 | 134 |
About Ritesh Agarwal
Ritesh Agarwal is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Physiology, Epidemiology and Surgery, having authored 548 papers that have together received 15.2k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (149 papers), Asthma and respiratory diseases (59 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (57 papers), Pleural and Pulmonary Diseases (44 papers), Respiratory Support and Mechanisms (43 papers), Tracheal and airway disorders (37 papers), Respiratory and Cough-Related Research (35 papers) and Lung Cancer Diagnosis and Treatment (32 papers). The work is most often cited by research in Infectious Diseases (5.3k citations), Pulmonary and Respiratory Medicine (6.5k citations), Critical Care and Intensive Care Medicine (616 citations), Physiology (3.1k citations) and Hepatology (768 citations). Ritesh Agarwal has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Ashutosh N. Aggarwal, Sahajal Dhooria, Dheeraj Gupta, Arunaloke Chakrabarti, Inderpaul Singh Sehgal, Valliappan Muthu, Surinder K. Jindal, Mandeep Garg, Digambar Behera and Dheeraj Gupta. Their work appears in journals such as Mycoses, CHEST Journal, Respiratory Care, Mycopathologia and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.